Umar, Sadiq
Palasiewicz, Karol
Meyer, Anja
Kumar, Prabhakaran
Prabhakar, Bellur S.
Volin, Michael V.
Rahat, Rani
Al-Awqati, Mina
Chang, Huan J.
Zomorrodi, Ryan K.
Rehman, Jalees
Shahrara, Shiva http://orcid.org/0000-0002-6698-8491
Funding for this research was provided by:
U.S. Department of Veterans Affairs (BX002286)
National Institute of Allergy and Infectious Diseases (AI147697)
Pfizer
Article History
Received: 16 December 2021
Revised: 26 April 2022
Accepted: 27 April 2022
First Online: 19 May 2022
Declarations
:
: The authors have declared that no commercial or financial conflict of interest exists.
: All peripheral blood (PB) was collected in accordance with our protocol approved by the University of Illinois at Chicago Institutional Ethics Review Board. Furthermore, all animal studies were approved by the University of Illinois at Chicago Animal Care and Use Committee following the legal requirements and guidelines of the state of Illinois in the USA and NIH. Dr. Prabhakar’s laboratory was responsible for the virus propagation experiments which were performed under BSL3 containment with approval of the University of Illinois at Chicago Institutional Biosafety Committee.
: All authors have been involved in writing the manuscript and consented to publication.
Free to read: This content has been made available to all.